Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Overview of the Application of Transcription Profiling Using Selected Nephrotoxicants for Toxicology Assessment

Jeffrey A. Kramer, Syril D. Pettit, Rupesh P. Amin, Timothy A. Bertram, Bruce Car, Michael Cunningham, Sandra W. Curtiss, John W. Davis, Clive Kind, Michael Lawton, Jorge M. Naciff, Victor Oreffo, Richard J. Roman, Frank D. Sistare, James Stevens, Karol Thompson, Alison E. Vickers, Stacey Wild and Cynthia A. Afshari
Environmental Health Perspectives
Vol. 112, No. 4, Toxicogenomics (Mar., 2004), pp. 460-464
Stable URL: http://www.jstor.org/stable/3837957
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Overview of the Application of Transcription Profiling Using Selected Nephrotoxicants for Toxicology Assessment
Preview not available

Abstract

Microarrays allow for the simultaneous measurement of changes in the levels of thousands of messenger RNAs within a single experiment. As such, the potential for the application of transcription profiling to preclinical safety assessment and mechanism-based risk assessment is profound. However, several practical and technical challenges remain. Among these are nomenclature issues, platform-specific data formats, and the lack of uniform analysis methods and tools. Experiments were designed to address biological, technical, and methodological variability, to evaluate different approaches to data analysis, and to understand the application of the technology to other profiling methodologies and to mechanism-based risk assessment. These goals were addressed using experimental information derived from analysis of the biological response to three mechanistically distinct nephrotoxins: cisplatin, gentamicin, and puromycin aminonucleoside. In spite of the technical challenges, the transcription profiling data yielded mechanistically and topographically valuable information. The analyses detailed in the articles from the Nephrotoxicity Working Group of the International Life Sciences Institute Health and Environmental Sciences Institute suggest at least equal sensitivity of microarray technology compared to traditional end points. Additionally, microarray analysis of these prototypical nephrotoxicants provided an opportunity for the development of candidate bridging biomarkers of nephrotoxicity. The potential future extension of these applications for risk assessment is also discussed.

Page Thumbnails

  • Thumbnail: Page 
460
    460
  • Thumbnail: Page 
461
    461
  • Thumbnail: Page 
462
    462
  • Thumbnail: Page 
463
    463
  • Thumbnail: Page 
464
    464